Comparison between DWARIKESH SUGAR INDUSTRIES IPO and INDOCO REMEDIES IPO.
DWARIKESH SUGAR INDUSTRIES IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while INDOCO REMEDIES IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
| DWARIKESH SUGAR INDUSTRIES IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Logo | ||
| Issue Category | Mainboard | Mainboard |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE, NSE | BSE, NSE |
| Lead Managers | ||
| Registrar | ||
| Market Maker | ||
| DRHP | ||
| RHP | ||
| Final Prospectus | Final Prospectus  | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL |
The total issue size of DWARIKESH SUGAR INDUSTRIES IPO is up to ₹32.53 Cr whereas the issue size of the INDOCO REMEDIES IPO is up to ₹73.50 Cr. The final issue price of DWARIKESH SUGAR INDUSTRIES IPO is ₹65.00 per share and of INDOCO REMEDIES IPO is ₹245.00 per share.
| DWARIKESH SUGAR INDUSTRIES IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹220.00 per share | |
| Issue Price (Upper) | ₹245.00 per share | |
| Issue Price (Final) | ₹65.00 per share | ₹245.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 50,04,285 shares | 30,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹32.53 Cr | up to ₹73.50 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 50,04,285 shares | 30,00,000 shares |
| Issue Size Total (Amount) | up to ₹32.53 Cr | up to ₹73.50 Cr |
DWARIKESH SUGAR INDUSTRIES IPO opens on Nov 29, 2004, while INDOCO REMEDIES IPO opens on Dec 17, 2004. The closing date of DWARIKESH SUGAR INDUSTRIES IPO and INDOCO REMEDIES IPO is Dec 03, 2004, and Dec 23, 2004, respectively.
DWARIKESH SUGAR INDUSTRIES IPO P/E ratio is , as compared to INDOCO REMEDIES IPO P/E ratio of .
In the DWARIKESH SUGAR INDUSTRIES IPO Retail Individual Investors (RII) are offered 22,50,000 shares while in INDOCO REMEDIES IPO retail investors are offered 22,50,000 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in DWARIKESH SUGAR INDUSTRIES IPO and 15,00,000 shares in INDOCO REMEDIES IPO.
| DWARIKESH SUGAR INDUSTRIES IPO | INDOCO REMEDIES IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 0 shares | 15,00,000 shares |
| NII | 22,50,000 shares | 7,50,000 shares |
| RII | 22,50,000 shares | 7,50,000 shares |
| Employee | 5,00,000 shares | 0 shares |
| Others | ||
| Total | 50,00,000 shares | 30,00,000 shares |
DWARIKESH SUGAR INDUSTRIES IPO subscribed in total, whereas INDOCO REMEDIES IPO subscribed .
